Australia markets closed

Purple Biotech Ltd (1YI1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.3640-0.0340 (-8.54%)
At close: 09:24AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
16,959
17,034
16,320
11,827
7,238
-
Selling general and administrative
4,261
4,842
5,962
5,821
5,708
-
Total operating expenses
21,615
22,271
22,603
17,934
13,239
-
Operating income or loss
-21,615
-22,271
-22,603
-17,934
-13,239
-
Interest expense
14
56
67
79
56
-
Total other income/expenses net
-
4,001
307
-133
-15,660
-
Income before tax
-18,855
-19,977
-21,760
-17,826
-28,701
-
Income tax expense
-
-
-
0
0
216
Income from continuing operations
-18,855
-19,977
-21,760
-17,826
-28,701
-
Net income
-18,764
-19,880
-21,668
-18,384
-27,999
-
Net income available to common shareholders
-18,764
-19,880
-21,668
-18,384
-27,999
-
Basic EPS
-1.05
-9.00
-1.20
-1.41
-2.44
-
Diluted EPS
-1.05
-9.00
-1.20
-1.41
-2.44
-
Basic average shares
20,274
2,213
18,081
17,568
11,500
-
Diluted average shares
20,274
2,213
18,081
17,568
11,500
-